Cancer immunology expert and former AACR president Elizabeth Jaffee, MD, FAACR, discusses the latest progress in the research on...
The American Association for Cancer Research (AACR) often participates in cancer-related Twitter chats, and we welcome Twitter novices and...
A recent study in the AACR’s journal Cancer Epidemiology, Biomarkers & Prevention confirms that there is no increased risk...
Yesterday, the U.S. Food and Drug Administration (FDA) announced the highly anticipated approval of the cancer immunotherapeutic pembrolizumab (Keytruda)...
The Stand Up To Cancer (SU2C) telecast on Friday, Sept. 5, is an important vehicle to fund highly meritorious...
Researchers have observed that diabetes seems to increase the risk of getting certain cancer types. In the summer issue...
Adults who smoked reduced-nicotine cigarettes did not smoke more intensely to compensate for the lower levels of nicotine, according...
Exercise equivalent to walking just four hours a week reduced a woman’s risk of invasive breast cancer by about...
When Bayer first introduced aspirin in 1899, the expectation from the drug was simple: alleviate headache, pain, and fever....
A report in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, illustrates the...
What is cancer immunotherapy, how does it work, and why are people so excited about it?